{"date":"2026-01-29","count":16,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6696-2026-01-29-2101-9ic1yx","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-01-29","time":"21:01:31","subject":"代重要子公司Belite Bio, Inc公告受邀參加第41屆亞太眼科學會(APAO)2026年會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-01-29 21:01，「代重要子公司Belite Bio, Inc公告受邀參加第41屆亞太眼科學會(APAO)2026年會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2026-01-29-1739-1fyr73b","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-29","time":"17:39:08","subject":"代重要子公司美國世基及新加坡世基公司公告法人董事改派代表人暨總經理","clause":"第6款","fact_date":"2026-01-29","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2026-01-29 17:39，「代重要子公司美國世基及新加坡世基公司公告法人董事改派代表人暨總經理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-01-29-1704-1vqqwem","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-01-29","time":"17:04:59","subject":"本公司辦理股票初次上市過額配售內容","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-01-29 17:04，「本公司辦理股票初次上市過額配售內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-01-29-1702-1bkmvqk","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-01-29","time":"17:02:35","subject":"本公司辦理股票初次上市前現金增資收足股款暨現金增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-01-29 17:02，「本公司辦理股票初次上市前現金增資收足股款暨現金增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2026-01-29-1657-11b1948","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-29","time":"16:57:07","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-01-29","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2026-01-29 16:57，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2026-01-29-1654-1bkm0mx","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-29","time":"16:54:54","subject":"公告本公司代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2026-01-29 16:54，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2026-01-29-1654-5lrh5b","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-29","time":"16:54:44","subject":"公告本公司董事會通過解除經理人競業禁止之限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2026-01-29 16:54，「公告本公司董事會通過解除經理人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2026-01-29-1654-40g0el","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-29","time":"16:54:34","subject":"公告本公司董事會通過營運長任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2026-01-29 16:54，「公告本公司董事會通過營運長任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2026-01-29-1654-i8tame","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-29","time":"16:54:19","subject":"公告本公司董事會通過總經理任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2026-01-29 16:54，「公告本公司董事會通過總經理任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2026-01-29-1628-b1lqh9","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2026-01-29","time":"16:28:11","subject":"公告本公司董事會決議限制員工權利新股之增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2026-01-29 16:28，「公告本公司董事會決議限制員工權利新股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2026-01-29-1556-2y1ekd","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-29","time":"15:56:02","subject":"公告本公司及GENTLEREGEN AG與法國LABORATOIRES FILL-MED公司簽署授權合約，收取階段里程碑達成金200萬歐元。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2026-01-29 15:56，「公告本公司及GENTLEREGEN AG與法國LABORATOIRES FILL-MED公司簽署授權合約，收取階段里程碑」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-01-29-1546-1l248wr","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-01-29","time":"15:46:33","subject":"公告本公司114年現金增資收足股款暨增資基準日","clause":"第51款","fact_date":"2026-01-29","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-01-29 15:46，「公告本公司114年現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-01-29-1545-1h096ep","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-01-29","time":"15:45:18","subject":"本公司與西門子醫療設備股份有限公司簽署策略合作意向書","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-01-29 15:45，「本公司與西門子醫療設備股份有限公司簽署策略合作意向書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-01-29-1534-1a9bi2a","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-01-29","time":"15:34:53","subject":"公告本公司財務主管、會計主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-01-29 15:34，「公告本公司財務主管、會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-01-29-1532-fics14","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-01-29","time":"15:32:07","subject":"本公司「放射治療器官自動勾勒系統（Seg Pro V3）」已取得美國食品藥物管理局（FDA）核發之 510(k) 許可，並通過(Predetermined Change Control Plans, PCCP）核可。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-01-29 15:32，「本公司「放射治療器官自動勾勒系統（Seg Pro V3）」已取得美國食品藥物管理局（FDA）核發之 510(k) 許可，」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2026-01-29-1520-br4i01","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-29","time":"15:20:24","subject":"公告本公司董事會決議115年股東常會相關事宜","clause":"第32款","fact_date":"2026-01-29","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2026-01-29 15:20，「公告本公司董事會決議115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}